<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:32:12Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2435163" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2435163</identifier><datestamp>2008-06-27</datestamp><setSpec>molvis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://dtd.nlm.nih.gov/ns/archiving/2.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://dtd.nlm.nih.gov/ns/archiving/2.3/ https://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article" xml:lang="EN">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title>Molecular Vision</journal-title>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2435163</article-id>
      <article-id pub-id-type="pmcid">PMC2435163</article-id>
      <article-id pub-id-type="pmc-uid">2435163</article-id>
      <article-id pub-id-type="pmid">18587495</article-id>
      <article-id pub-id-type="publisher-id">135</article-id>
      <article-id pub-id-type="publisher-id">2007MOLVIS0068</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kane</surname>
            <given-names>Rosemary</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Godson</surname>
            <given-names>Catherine</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>OâBrien</surname>
            <given-names>Colm</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>School of Medicine and Medical Science, UCD Conway Institute and UCD Diabetes Research Centre, University College Dublin, Belfield, Dublin 4, Ireland</aff>
        <aff id="aff2"><label>2</label>Institute of Ophthalmology, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to: Prof. Catherine Godson, School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland; Phone: +353 1 716 6731; FAX: +353 1 716 6701; email: <ext-link ext-link-type="uri" xlink:href="mailto:catherine.godson@ucd.ie">catherine.godson@ucd.ie</ext-link></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <fpage>1138</fpage>
      <lpage>1148</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>3</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>4</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Molecular Vision</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>Pericytes play a specialized role in regulating angiogenesis and vascular function by providing vascular stability and controlling endothelial cell proliferation. Disorders in pericyte function and pericyte-endothelial interaction have been observed in several disease states including tumor angiogenesis and diabetic microangiopathy. In ischemic retinal disease, hypoxia is a potent driver of retinal angiogenesis. This study investigated the effects of hypoxia on retinal pericyte gene expression, and demonstrates a role in angiogenesis regulation for the hypoxia driven gene, chordin-like 1 (<italic>CHL-1</italic>).</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>In the current studies, we investigated hypoxia-induced gene expression in human retinal pericytesÂ and found thatÂ expression of CHL-1, a member of the bone morphogenetic protein (BMP) superfamily, is upregulated by hypoxia. We investigated regulation of <italic>CHL-1</italic> expression and the ability ofÂ CHL-1 to antagonize the antiangiogenic properties of BMP-4 using a human cell-based angiogenesis assay.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We report that hypoxia induced hypoxia inducible factor-1Î±-driven expression of CHL-1. Both CHL-1 and BMP-4 were secreted from human retinal pericytes. We found that CHL-1 complexes with BMP-4 to antagonize the antiangiogenic effects of BMP-4, and that BMP-4 and vascular endothelial growth factor (VEGF) co-regulate angiogenesis.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We propose that hypoxia-induced upregulation of CHL-1 alters the homeostatic balance betweenÂ BMP-4 and VEGFÂ toÂ synergizeÂ withÂ VEGF in driving retinal angiogenesis.</p>
        </sec>
      </abstract>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>f4-style</meta-name>
          <meta-value>two-thirds</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>f5-style</meta-name>
          <meta-value>two-thirds</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Diabetic retinopathy is a microvascular complication of both Type 1 and Type 2 diabetes and is characterized by increased tissue ischemia, angiogenesis, and permeability. This microvascular disease is a major cause of blindness in the working age population [<xref ref-type="bibr" rid="r1">1</xref>]. The development of diabetic retinopathy reflects the convergence of hemodynamic and metabolic insults, including hyperglycemia, in susceptible individuals.</p>
      <p>Vascular endothelial growth factor (VEGF) is known to be induced by hypoxia and may mediate hypoxia-induced angiogenesis [<xref ref-type="bibr" rid="r2">2</xref>]. VEGF alone is sufficient to produce many of the vascular abnormalities common to diabetic retinopathy and other ischemic retinopathies, such as hemorrhage, edema, venous beading, capillary occlusion with ischemia, microaneurysm formation, and intraretinal vascular proliferation [<xref ref-type="bibr" rid="r3">3</xref>].</p>
      <p>Retinal pericytes are smooth muscle-like cells with attenuated processes enveloping the abluminal surface of microvessels and sharing a common basement membrane with the underlying endothelium (reviewed in [<xref ref-type="bibr" rid="r4">4</xref>]). Pericytes express alpha-smooth muscle actin and have thus been implicated to have a contractile function [<xref ref-type="bibr" rid="r5">5</xref>]. They are proposed to regulate microvascular angiogenesis and synthesize components of the vascular basement membrane [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. Pericytes have been demonstrated to be involved in the regulation of endothelial cell number and morphology and microvessel architecture [<xref ref-type="bibr" rid="r8">8</xref>].</p>
      <p>In this study we present novel findings that chordin-like 1 (CHL-1), a bone morphogenetic protein (BMP) antagonist [<xref ref-type="bibr" rid="r9">9</xref>], is upregulated by hypoxia in human retinal pericytes, and that its expression is driven by hypoxia inducible factor-1Î± (HIF-1Î±). CHL-1 has previously been reported to be expressed in the developing retina [<xref ref-type="bibr" rid="r9">9</xref>], but has not yet been associated with diabetic or ischemic retinopathy. BMP-4 has been implicated in angiogenesis through a VEGF-dependent mechanism [<xref ref-type="bibr" rid="r10">10</xref>]. We therefore propose that CHL-1 expression by human retinal pericytes in response to hypoxia may play an important role in regulating retinal angiogenesis through modulation of BMP-4 actions on endothelial cells.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Cell culture and hypoxia</title>
        <p>Primary cultures of human retinal pericytes (hRPC) were obtained from Cambrex (Nottingham, UK) and were cultured in <ext-link ext-link-type="uri" xlink:href="https://invitrogen.custhelp.com/cgi-bin/invitrogen.cfg/php/enduser/std_adp.php?p_faqid=115">MCDB131</ext-link> medium (Invitrogen, Paisley, Scotland) supplemented with 2Â mM L-glutamine 50 U/ml penicillin, 50Â Î¼g/ml streptomycin, and 10% (v/v) fetal bovine serum. For experiments, cells were used at passage four or less and maintained in medium with 10% serum. HeLa (LGC promochem, Teddington, UK) cells were cultured in minimum essential medium (Sigma, Dublin, Ireland) supplemented with 10% (v/v) fetal bovine serum, 2Â mM L-glutamine, 50 U/ml penicillin, 50Â Î¼g/ml streptomycin, and non-essential amino acids (Sigma). Cos7 (LGC Promochem) cells were cultured in DMEM (Cambrex) supplemented with 10% (v/v) fetal bovine serum, 2Â mM L-glutamine, 50 U/ml penicillin, and 50Â Î¼g/ml streptomycin.</p>
        <p>For hypoxia experiments, cells were placed in an hypoxia chamber (Coy Laboratories, Grass Lake, MI) allowing the establishment of humidified, ambient, atmospheric hypoxia of 1% O<sub>2</sub> with 5% CO<sub>2</sub> and a balance of N<sub>2</sub>. Temperature was maintained at 37Â Â°C. Extracellular pO<sub>2</sub> measurements were made by using fluorescence quenching oxymetry (Oxylite-2000; Oxford Optronix, Oxford, UK).</p>
      </sec>
      <sec>
        <title>RNA extraction and cDNA synthesis</title>
        <p>RNA was extracted from hRPC using RNeasy kit (Qiagen, Crawley, UK) according to the manufacturerâs instructions. RTâPCR was performed as follows: 2Â Î¼g of total RNA was treated with DNaseI (Invitrogen), according to the manufacturerâs instructions, to remove chromosomal DNA. Reverse transcription was performed using random primer (Invitrogen) and Superscript II (Invitrogen) using the manufacturerâs protocol.</p>
        <p>Limited cycle PCR was performed using the following primers, designed using the Primer3 software described in (<xref ref-type="table" rid="t1">Table 1</xref>) [<xref ref-type="bibr" rid="r11">11</xref>].</p>
        <table-wrap id="t1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Limited cycle and real time PCR primers</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="41" span="1"/>
            <col width="126" span="1"/>
            <col width="126" span="1"/>
            <col width="162" span="1"/>
            <tbody>
              <tr>
                <td valign="bottom" colspan="4" align="left" scope="col" rowspan="1">
                  <bold>Limited cycle PCR primers</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">Gene<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Sense primer 5â²-3â²</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Antisense primer 5â²-3â²</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Probe 5â²-3â²</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>VEGF</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">CTGCTCTACCTCCACCATGC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">CTGCATTCACATTTGTTGTGC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>CHL-1</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">TCTGTCACCTTTTGCAGTGG<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">GTTGCCGATTCTGAA AGAGC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>Cox2</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">AACAGGAGCATCCTGAATGG<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">ATTTCATCTGCCTGCTCTGG<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>RTP801</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">TCTTAGCAGTTCTCGCTGACC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">TGGCACACAAGTGTTCATCC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>BMP-2</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">CAAGATGAACACAGCTGG<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">TTTGCTGTACTAGCGACACC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>BMP-4</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">GGCTGTCAAGAATCATGG<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">GCTCAGGATACTCAAGAC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>18S</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                  <bold>Real time PCR primers</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Sense primer 5â²-3â²</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Antisense primer 5â²-3â²</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Probe 5â²-3â²</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>VEGF</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">GTGCCCACTGAGGAGTCCA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">GTGCTGGCCTTGGTGAGGT<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">CATCACCATGCAGATTATGCGGATCAA<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>Cox2</italic>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">AGCCCTTCCTCCTGTGCCT<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">CAGGAAGCTGCTTTTTACC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">TGATTGCCCGACTCCCTTG<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">
                  <italic>CHL-1</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">CGTAGCTGAAGGGCTCTTT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">ACACGTTTCCCTCCGAACA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">AAATCGGCAACCCAATCAAT</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Limited cycle PCR was performed using primers, designed using <ext-link ext-link-type="uri" xlink:href="http://fokker.wi.mit.edu/primer3/input.htm">Primer3</ext-link> software [11]. For real-time, PCR probes were labeled with 5â²-FAM and 3â²-TAMRA as quencher with the exception of the ribosomal probe, which was labeled with 5â²-VIC to facilitate multiplexing.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Real-time (Taqman) polymerase chain reaction</title>
        <p>Real-time (Taqman) polymerase chain reaction transcript levels were determined by real-time PCR using a PerkinElmer 7700 analyzer (Perkin Elmer Life Sciences, Shelton, CT). Probe and primer sequences were described in <xref ref-type="table" rid="t1">Table 1</xref>. Probes were labeled with 5â²-FAM and 3â²-TAMRA as quencher with the exception of the ribosomal probe, which was labeled with 5â²-VIC to facilitate multiplexing. All results were normalized to 18S rRNA (pre-developed assay reagent, PerkinElmer Life Sciences).</p>
      </sec>
      <sec>
        <title>Gene microarray analysis</title>
        <p>RNA isolation was performed as described in the previous section. In vitro transcription and microarray analysis were performed as follows: 5Â Î¼g of total RNA were annealed to 100 pmol of the T7-(dT)24 primer. Then first-strand cDNA synthesis was completed by incubating the mixture with 1Â Î¼l of Superscript II RT (200 units) at 42Â Â°C for 1 h. Second-strand synthesis was performed in a total volume of 150Â Î¼l. Following purification, the cDNA was extracted with phenol chloroform, precipitated with ammonium acetate, and resuspended in RNase-free water. Synthesis of cRNA was performed by in vitro transcription. The amplified cRNA was purified with an affinity resin column. Biotin-labeled cRNA prepared from template cDNAs was fragmented and hybridized to the HG U133A array (Affymetrix, High Wycombe, UK). Arrays were then washed and fluorescently labeled before being scanned using a confocal scanner. Microarray Suite 5.1 software (Affymetrix) was used to analyze the relative abundance of each gene from the average difference of fluorescent intensities. Calculated signal/log ratios for each gene at all time points of hypoxia were compared to normoxia, and those genes with a value greater than 0.6 or less than â0.6 (1.5 fold difference) in all three biologic replicate experiments were examined further.</p>
      </sec>
      <sec>
        <title>Cloning of the chordin-like 1 promoter and open reading frame</title>
        <p>A 1537 bp fragment of the <italic>CHL-1</italic> promoter was amplified using the Advantage2 PCR enzyme system (BD Biosciences, Oxford, UK) from a human genomic library EMBL3 SP6/T7 (HL 1067 J, BD Biosciences) with the following primers, sense 5â²-GGA GAT AAC AAC CAG AGA GTA GTG G-3â² and, antisense 5â²-GAA AAG GAG GTG AGG GAA GC-3â². The PCR product was immediately cloned into the TA cloning vector pCRII-TOPO (Invitrogen). The plasmid was restricted using the enzymes Kpn1 (NEB) and Xho1 (NEB), the resulting promoter fragment was subcloned into the reporter vector pGL3 Basic (Promega Southampton, UK).</p>
        <p>The open reading frame of <italic>CHL-1</italic> was amplified using the Advantage2 PCR enzyme system (BD Biosciences) using human retinal pericyte cDNA as a template. A sense primer with a BamH1 site, 5â²-GCT CGG ATC CGC CTG TCA CCT TTT GCA GTG GTC-3â², and an antisense primer with an EcoR1 site, 5â²-TGC AGA ATT CGC TTA CAG TGG CCC TTT TCA GAT C-3â², were used to generate CHL-1 expression from a parent vector, pcDNA6/V5-His C (Invitrogen), designated pcDNA6 CHL-1/V5-His.</p>
      </sec>
      <sec>
        <title>Overexpression of hypoxia inducible factor-1Î±</title>
        <p>Wild-type (WT) and double mutant (DM) constructs expressing HIF-1Î± were a gift from Thilo Hagen (University College London, London, UK). Prolines 564 and 402 were mutated to alanine, as these are the residues important for targeted degradation in normoxia [<xref ref-type="bibr" rid="r12">12</xref>]. Pericytes were transfected, according to manufacturerâs protocol, with 4 Âµg of each construct using 12 Âµl Fugene 6 (Roche, Dublin, Ireland). After 24 h following transfection, the medium was changed and the cells were incubated for a further 24 h. RNA was then isolated and analyzed by RTâPCR, or nuclear protein extracts were examined by western blot analysis to detect HIF-1Î± protein.</p>
      </sec>
      <sec>
        <title>Luciferase assays</title>
        <p>HeLa cells were transfected with plasmids pGL3-CHL-1 or pGL3-HRE [<xref ref-type="bibr" rid="r13">13</xref>] along with DM-HIF-1Î±, using 6 Âµl Fugene 6 (Roche). Cells were transfected for 24 h, medium replaced with fresh and incubated for a further 24 h. Cells transfected with DM-HIF-1Î± were incubated in normoxia, and cells transfected without DM-HIF-1Î± were incubated in hypoxia. Luciferase gene reporter assay was performed according to the manufacturerâs instructions (Promega).</p>
      </sec>
      <sec>
        <title>Analysis of chordin-like 1 and bone morphogenetic protein â4 complex formation</title>
        <p>Cos7 cells were transfected as described previously with either empty vector, pcDNA/V5-HisC, or with the CHL-1 expression vector, pcDNA6 CHL-1/V5-His. Cells were lysed, and whole cell extracts were made. Next, 50 Âµl of extract was incubated with 250 ng rhBMP-4 (R&amp;D Systems, Abingdon, UK) for 1 h at 4Â Â°C before incubation with 100 Âµl Ni-NTA magnetic beads, overnight at 4Â Â°C with constant rocking. Ni-NTA magnetic beads had been previously washed with binding buffer, pH 8.0, that contained 50Â mM NaH<sub>2</sub>PO<sub>4</sub>, 300Â mM NaCl, 10Â mM imidazole, and 0.05% Tween 20. Complexes were washed in wash buffer, pH 8.0, that contained 50Â mM NaH<sub>2</sub>PO<sub>4</sub>, 300Â mM NaCl, 20Â mM imidazole, and 0.05% Tween 20, and eluted off the magnetic beads with elution buffer, pH 8.0, that contained 50Â mM NaH<sub>2</sub>PO<sub>4</sub>, 300Â mM NaCl, 250Â mM imidazole, and 0.05% Tween 20. Samples were electrophoresed on SDSâPAGE gels, transferred to PVDF membranes, and probed for either V5-tagged CHL-1 or BMP-4.</p>
        <table-wrap id="t2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Differential gene expression in human retinal pericytes exposed to hypoxia.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="60" span="1"/>
            <col width="63" span="1"/>
            <col width="243" span="1"/>
            <col width="36" span="1"/>
            <tbody>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Number</bold>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Accession number</bold>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Description</bold>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <bold>SLR</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                  <bold>Upregulated genes</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4557440">NM_000076.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 1C (p57, Kip2, CDKN1C) <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.7<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4506264">NM_000963.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">prostaglandin-endoperoxide synthase 2 (prostaglandin GH synthase and cyclooxygenase, PTGS2)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.43<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">3<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=7019408">NM_013332.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">hypoxia-inducible protein 2 (HIG2)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.43<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=13528920">BC005254.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">Similar to C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 2 (activation-induced), clone MGC:12289<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.4<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">5<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=21536395">NM_016109</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">PPAR(gamma) angiopoietin related protein (PGAR)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.36<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">6<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=8119287">AF064238.3</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">smoothelin large isoform L2 (SMTN)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.26<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">7<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=3719220">AF022375.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">vascular endothelial growth factor<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.26<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">8<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=7662375">NM_014883.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">KIAA0914 gene product (KIAA0914)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.16<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">9<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=9945331">NM_015675.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">growth arrest and DNA-damage-inducible, beta (GADD45B) <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.13<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">10<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4504570">NM_002166.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">11<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=8922146">NM_017606.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">hypothetical protein DKFZp434K1210 (DKFZp434K1210)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">12<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=13477306">BC005127.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">adipose differentiation-related protein, clone MGC:10598 <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">13<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=10047137">NM_020142.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">NADH:ubiquinone oxidoreductase MLRQ subunit homolog (LOC56901)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">14<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=6806883">NM_003734.2</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">amine oxidase, copper containing 3 (vascular adhesion protein 1, AOC3)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">1<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">15<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=5902089">NM_006931.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.96<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">16<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=688112">S73751.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">acyl CoA:cholesterol acyltransferase<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.93<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">17<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&amp;id=5936493">AL048423.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">EST: integrin, beta 5<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">18<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4503328">NM_003897.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">immediate early response 3 (IER3)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">19<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4885130">NM_005195.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CCAATenhancer binding protein (CEBP), delta (CEBPD) <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">20<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4808226">AL049176</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">DNA sequence from clone 141H5 on chromosome Xq22.1â23. Contains parts of a novel Chordin LIKE protein with von Willebrand factor type C domains.<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">21<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=10190675">NM_020639.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">ankyrin repeat domain 3 (ANKRD3)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">22<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4506482">NM_002912.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1"> REV3 (yeast homolog)-like, catalytic subunit of DNA polymerase zeta (REV3L)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.83<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">23<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4506250">NM_000954.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">prostaglandin D2 synthase (21kD, brain; PTGDS)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.83<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">24<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=12652748">BC000125.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">Similar to transforming growth factor, beta 1, clone MGC:3119 <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.76<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">25<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&amp;id=3412575">AI078167</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">EST: nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.76<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">26<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4885516">NM_005384.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">nuclear factor, interleukin 3 regulated (NFIL3)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.76<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">27<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=9506686">NM_019058.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">hypothetical protein (FLJ20500), mRNA. RTP801<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.73<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">28<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4503298">NM_003670.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">basic helix-loop-helix domain containing, class B, 2 (BHLHB2) <hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">0.66<hr/></td>
              </tr>
              <tr>
                <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                  <bold>Downregulated genes</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4505414">NM_000903.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">diaphorase (NADHNADPH, cytochrome b-5 reductase, DIA4)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-2.16<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=4507456">NM_003234.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">transferrin receptor (p90, CD71, TFRC)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-1.53<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">3<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=13346507">NM_020299.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">aldo-keto reductase family 1, member B10 (AKR1B10)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-1.53<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=8922419">NM_018092.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">neuropilin (NRP) and tolloid (TLL)-like 2 (NETO2)<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-1.23<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">5<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=178099">M21692.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">class I alcohol dehydrogenase (ADH2) beta-1 subunit<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-1<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">6<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=662289">D45421.1</ext-link>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">mRNA for phosphodiesterase I alpha<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">-0.86<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">7</td>
                <td valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=10433168">AK021882.1</ext-link>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">cDNA FLJ11820 fis, clone HEMBA1006445, highly similar to putative tumor supressor NOEY2</td>
                <td valign="top" align="left" rowspan="1" colspan="1">-0.76</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>The transcriptional response of human retinal pericytes to hypoxia was examined by microarray analysis, the SLR (signal-log ratio) is the mean value of three independent experiments.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Western blot analysis</title>
        <p>Western blot analysis was performed by standard procedures [<xref ref-type="bibr" rid="r14">14</xref>]. HIF-1Î± protein levels were detected using a 1:500 dilution of either anti-HIF-1Î± (Biomol) or anti-HIF-1Î± antibody (AbCam, Canbridge, UK). V5-tagged CHL-1 was detected using a 1:5000 dilution of the anti-V5 antibody (Invitrogen). BMP-2 and BMP-4 was detected using 1:500 dilutions of the anti-BMP-2 and anti-BMP-4 antibodies (R&amp;D Systems). CHL-1 was detected using a 1:1000 dilution of anti-CHL-1 antibody (R&amp;D Systems).</p>
      </sec>
      <sec>
        <title>Angiogenesis assay</title>
        <p>Human umbilical vascular endothelial cells and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates (AngioKit, TCS CellWorks Ltd., Buckingham, UK). Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. Treatments were recombinant human BMP-2, BMP-4, and CHL-1 (R&amp;D Systems). In addition, 2 ng/ml VEGF and 20Â Î¼M Suramin (TCS Cellworks) were used as positive and negative controls respectively. Tubule formation was examined at day 11. Cells were fixed with ice-cold 70% ethanol and tubules were quantitated and visualized following fixing and staining for CD31 platelet-endothelial cell adhesion molecule 1 (PECAM-1) using a combined ELISA and histology kit (TCS CellWorks Ltd., UK) according to the manufacturer's instructions. Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, Ï-nitrophenol phosphate, which permits quantitation by an optical density measurement. Plates were subsequently washed and stained using an insoluble substrate, 5-Bromo-4-chloro-3-indolyl phosphate (BCIP)/Nitroblue tetrazolium (NBT), for tubule visualization.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Each result was representative of at least three independent experiments. All values are represented as the mean Â±standard error of measurement. The Student <italic>t</italic>-test was used to determine statistical differences. Significance of results was indicated when p&lt;0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Upregulation of chordin-like 1 in human retinal pericytes in response to hypoxia</title>
        <p>The transcriptomic response of human retinal pericytes to hypoxia was examined. The mean signalâlog ratio of three independent experiments is shown (<xref ref-type="table" rid="t2">Table 2</xref>). Using oxygen quenching oxymetry, we determined extracellular oxygen tensions at the level of the monolayer. Cells cultured in normoxia had a mean pO<sub>2</sub> measurement of 140Â±2.79Â mmHg, cells cultured in hypoxia had a mean pO<sub>2</sub> measurement of 2.12Â±0.94Â mmHg. The ambient pO<sub>2</sub> in the hypoxia chamber was 6.21Â±0.08Â mmHg (data not shown).</p>
        <p><italic>CHL-1</italic> (upregulated gene number 20) is a novel gene not previously associated with diabetic retinopathy [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>]. <italic>CHL-1</italic> was upregulated in pericytes by hypoxia with a mean SLR of 0.9, corresponding to a 1.9 fold increase in expression (p&lt;0.001). Two genes previously known to be associated with diabetic retinopathy were also upregulated: <italic>VEGF</italic> (upregulated gene number 7) is implicated in diabetic retinopathy, contributing to endothelial proliferation, permeability, and angiogenesis [<xref ref-type="bibr" rid="r2">2</xref>], and is known to be upregulated in pericytes in response to hypoxia [<xref ref-type="bibr" rid="r17">17</xref>]. <italic>VEGF</italic> was upregulated in pericytes by hypoxia with a mean SLR of 1.26, corresponding to a 2.4 fold increase in expression (p&lt;0.001), and <italic>Cox2</italic> (upregulated gene number 2) is associated with neovascularisation in models of retinopathy [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. <italic>Cox2</italic> was upregulated in pericytes by hypoxia with a mean SLR of 1.43, corresponding to a 2.7 fold increase in expression (p&lt;0.05). To examine the upregulation of <italic>CHL-1</italic> along with genes known to be upregulated in diabetic retinopathy, we performed real-time quantitative PCR. As determined by quantitative PCR over a time course (0, 6, 24 and 48 h) of exposure to hypoxia (1% O<sub>2</sub>), <italic>CHL-1</italic> mRNA was upregulated 1.7 fold by 48 h (p&lt;0.05; <xref ref-type="fig" rid="f1">Figure 1A</xref>), and <italic>VEGF</italic> and <italic>Cox 2</italic> mRNAs were upregulated twofold by 48 h (p&lt;0.05; <xref ref-type="fig" rid="f1">Figure 1B,C</xref>).</p>
        <fig id="f1" fig-type="figure" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Validation of three genes differentially expressed in human retinal pericytes (hRPC) in response to hypoxia. The upregulation of a selection of genes was validated with real time PCR, using a PerkinElmer 7700 analyzer, on cDNA generated from human retinal pericytes exposed to increasing periods of hypoxia (0, 6, 24, and 48 h). All results were normalized to 18S rRNA, using a pre-developed assay reagent. Data are expressed as mean relative quantity of mRNA, relative to control, for three independent experiments Â±standard error of measurement for (<bold>A</bold>) <italic>CHL-1</italic> mRNA, (<bold>B</bold>) <italic>VEGF</italic> mRNA, and (<bold>C</bold>) <italic>Cox 2</italic> mRNA. Data are expressed as meanÂ±SEM values. The asterisk indicates a significance at p&lt;0.05 and the double asterisk indicates a significance at p&lt;0.001.</p>
          </caption>
          <graphic xlink:href="mv-v14-1138-f1"/>
        </fig>
      </sec>
      <sec>
        <title>Chordin-like 1 expression is directly transactivated by hypoxia inducible factor-1Î±</title>
        <p>The upstream region of <italic>CHL-1</italic> was identified using the <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">Human Genome Browser</ext-link> Gateway at the UCSC interface. A 1537 bp fragment of the <italic>CHL-1</italic> promoter was cloned, sequenced and inserted into the reporter vector pGL3 Basic (Promega), and named pGL3 CHL-1. Bioinformatic analysis of transcription factors binding to this region of the promoter was performed using <ext-link ext-link-type="uri" xlink:href="http://www.genomatix.de">MatInspector</ext-link><sup>TM</sup> software, and a putative HIF-1Î± binding site was located in the proximal promoter (data not shown).</p>
        <p>Human retinal pericytes were exposed to 1% O<sub>2</sub> for 0, 6, 24, and 48 h. Nuclear and cytosolic extracts were prepared and used for western blotting. HIF-1Î± protein expression was dramatically increased by 6 h of hypoxia and remained elevated by 48 h (<xref ref-type="fig" rid="f2">Figure 2A</xref>).</p>
        <fig id="f2" fig-type="figure" position="float">
          <label>Figure 2</label>
          <caption>
            <p>HIF-1Î± drives expression of chordin-like 1 in retinal pericytes exposed to hypoxia. <bold>A</bold>: western blot analysis of nuclear extracts generated from human retinal pericytes exposed to increasing periods of hypoxia (0, 6, 24, and 48 h) for HIF-1Î± shows upregulation of the protein by 6 h. <bold>B</bold>: Transfection of human retinal pericytes maintained in normoxia with expression vectors for HIF-1 Î±, C is control/empty vector, WT is wild type vector, WT-HIF-1 Î±, DM is double mutant vector, DM-HIF-1 Î±, using the transfection reagent Fugene6, induces expression of many of the genes upregulated in response to hypoxia, as measured by RTâPCR. 18S PCR is shown as a loading control and western blot analysis confirmed expression from each of the HIF-1Î± expressing plasmids. <bold>C</bold>: Induction of <italic>CHL-1</italic> mRNA in response to HIF-1Î± overexpression was quantitated by real time PCR. <italic>CHL-1</italic> levels were normalized to 18S rRNA, using a pre-developed assay reagent. Data are expressed as mean relative quantity of mRNA, to control, for three independent experiments Â±standard error of measurement. <bold>D</bold>: HeLa cells were transfected, using the transfection reagent Fugene6, with the <italic>CHL-1</italic> promoter or a luciferase reporter construct containing four HIF-1Î± responsive elements (HRE), alone (control), cotransfected with the HIF-1Î± expression vector DM-HIF-1Î±, or alone and subsequent exposure to hypoxia for 24 h (1% O<sub>2</sub>). Cotransfection with DM-HIF-1Î± as well as exposure to hypoxia induced activation of the CHL-1 promoter and the HRE construct. Data are expressed as meanÂ±SEM values. The asterisk indicates a significance at p&lt;0.05 and the double asterisk indicates a significance at p&lt;0.001.</p>
          </caption>
          <graphic xlink:href="mv-v14-1138-f2"/>
        </fig>
        <p>To determine if the <italic>CHL-1</italic> promoter with the putative HIF-1Î± binding sequences was truly HIF-1Î± responsive, we transfected WT and DM constructs expressing HIF-1Î± into retinal pericytes. Semiquantitative RTâPCR was performed on RNA isolated from these cells for genes known to be HIF-1Î± responsive, <italic>VEGF</italic> and <italic>Cox2</italic>, and for the novel hypoxia regulated gene <italic>CHL-1</italic>. In addition, 18S rRNA PCR was performed as a loading control (<xref ref-type="fig" rid="f2">Figure 2B</xref>). Expression of the transiently transfected HIF-1Î± is also shown in <xref ref-type="fig" rid="f2">Figure 2</xref>. The level of <italic>CHL-1</italic> mRNA expression in these transiently transfected cells was quantitated using real-time PCR (<xref ref-type="fig" rid="f2">Figure 2C</xref>). Overexpression of HIF-1Î± was confirmed by western blotting (<xref ref-type="fig" rid="f2">Figure 2B</xref>).</p>
        <p>To further determine the response of the <italic>CHL-1</italic> promoter to HIF-1Î±, we transfected HeLa cells with pGL3 CHL-1 and either stimulated with 1% O<sub>2</sub> or transfected with pGL3 CHL-1 and DM-HIF-1Î±. As a control, the experiment was also performed using a promoter reporter construct containing four hypoxia responsive elements driving the luciferase gene, HRE-Luc, instead of pGL3 CHL-1. The <italic>CHL-1</italic> promoter was driven greater than threefold by HIF-1Î± (p&lt;0.05) and greater than twofold by hypoxia (p&lt;0.05). The control promoter reporter construct, which contains four hypoxia responsive elements (HREs) was driven greater than fourfold by HIF-1Î± and greater than sixfold by hypoxia (both p&lt;0.001; <xref ref-type="fig" rid="f2">Figure 2D</xref>).</p>
      </sec>
      <sec>
        <title>Chordin-like 1 expressed in human retinal pericytes is secreted and binds to bone morphogenetic protein-4</title>
        <p><italic>CHL-1</italic> mRNA was expressed in response to hypoxia in retinal pericytes (<xref ref-type="fig" rid="f1">Figure 1C</xref>). The protein sequence for CHL-1 contained a signal peptide. Conditioned media (20Â Î¼l) from retinal pericytes exposed to hypoxia was examined by western blotting for secretion of CHL-1 using an anti-CHL-1 antibody (R&amp;D Systems). Secreted CHL-1 was detectable in the conditioned media and was upregulated by hypoxia, correlating with the mRNA data (<xref ref-type="fig" rid="f3">Figure 3A</xref>). CHL-1 is a BMP antagonist and previously shown to bind BMP-2 [<xref ref-type="bibr" rid="r20">20</xref>] and BMP-4 [<xref ref-type="bibr" rid="r9">9</xref>]. We investigated the expression of both these BMPs in retinal pericytes in response to normoxia and hypoxia. Both were expressed at the mRNA level (<xref ref-type="fig" rid="f3">Figure 3B</xref>) and were secreted into the culture media as detected by western blotting (<xref ref-type="fig" rid="f3">Figure 3C</xref>). Exposure to hypoxia had no significant expression on either BMP-2 or BMP-4 expression.</p>
        <fig id="f3" fig-type="figure" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Chordin-like 1 expressed in human retinal pericytes is secreted and binds to bone morphogenetic protein-4. <bold>A</bold>: Conditioned media from HRPC exposed to 1% O<sub>2</sub> for 24 and 48 h was examined by western blot analysis for secretion of CHL-1, using an anti-CHL-1 antibody. <bold>B</bold> and <bold>C</bold>: BMP-2 and BMP-4 expression in HRPC was examined in cells cultured in normoxia (N) and hypoxia (H) by RTâPCR (B) and secreted BMP2 and BMP-4 were detected in conditioned media from HRPC exposed to 1% O<sub>2</sub> for 24 and 48 h (C). <bold>D:</bold> Transfection of the expression vector pcDNA6/CHL-1 V5-His into Cos7 cells, using the transfection reagent Fugene 6, resulted in expression of an approximately 60 kDa protein, which was detectable using an anti-V5 antibody. Cells were transfected with either an empty vector (E), pcDNA6/V5-His C, or a V5 tagged CHL-1 expressing vector (CHL-1), pcDNA6/CHL-1 V5-His. <bold>E:</bold> Whole cell extracts from Cos7 cells were transfected, using the transfection reagent Fugene 6, with empty pcDNA6/V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1, were incubated with 250 ng rhBMP-4 and 100 ml NiNTA magnetic beads at 4Â Â°C overnight. The complexes were washed, the beads and examined by western blotting for the presence of CHL-1, using anti-V5 antibody, and BMP-4, using an anti-BMP-4 antibody.</p>
          </caption>
          <graphic xlink:href="mv-v14-1138-f3"/>
        </fig>
        <p>The open reading frame of <italic>CHL-1</italic> was cloned and sequenced, and inserted inframe with the COOH-terminal V5 6xHis tag in the expression vector pcDNA6/V5His, and named pcDNA6 CHL-1/V5His. Cos7 cells were transfected with empty pcDNA6V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1. Whole cell extracts were examined by western blotting for V5 tagged CHL-1 expression using an anti-V5 antibody (Invitrogen; <xref ref-type="fig" rid="f3">Figure 3D</xref>) Whole cell extracts from Cos7 cells transfected with empty pcDNA6/V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1, were incubated with 250 ng rhBMP-4 (R&amp;D Systems) and 100Â ml NiNTA magnetic beads at 4Â Â°C overnight with rotation. The interaction of the two proteins was demonstrated by pulling down any complexes formed with the tagged CHL-1 using NiNTA magnetic beads (Qiagen) which bound the 6xHis tag on the expressed CHL-1. Proteins bound in a complex to CHl-1 were washed with wash buffer and then eluted using elution buffer. Western blotting was used to identify eluted proteins. CHl-1 was detected using anti-V5 antibody (Invitrogen), and BMP-4, using an anti-BMP-4 antibody (R&amp;D Systems). The complexes bound to the Ni-NTA magnetic beads contained both CHL-1 and BMP-4 (<xref ref-type="fig" rid="f3">Figure 3</xref>E).</p>
      </sec>
      <sec>
        <title>Bone morphogenetic protein-4 inhibits angiogenesis and is antagonized by chordin-like 1</title>
        <p>BMPs have been previously reported to be negative growth regulators in the adult retinal pigmented epithelium [<xref ref-type="bibr" rid="r21">21</xref>], and, more specifically, BMP-4 has been demonstrated to mediate apoptosis of capillary endothelial cells [<xref ref-type="bibr" rid="r22">22</xref>]. We wanted to determine the angiogenic effects of BMPs and CHL-1 using an in vitro angiogenesis assay (AngioKit, TCS Cellworks). Using 2 ng/ml VEGF and 20Â Î¼M Suramin as positive and negative controls, respectively, we successfully stimulated (p&lt;0.001) and inhibited (p&lt;0.001) angiogenesis (<xref ref-type="fig" rid="f4">Figure 4A,D</xref>). While 10 ng/ml BMP-2 appeared to negatively regulate angiogenesis, this effect was not significant; however, 10 ng/ml BMP-4 significantly inhibited angiogenesis (p=0.0015; <xref ref-type="fig" rid="f5">Figure 5B,D</xref>). CHL-1 alone had no effect on angiogenesis; however, it reversed the inhibitory effect of BMP-4 (<xref ref-type="fig" rid="f4">Figure 4C,D</xref>).</p>
        <fig id="f4" fig-type="figure" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Chordin-like 1 modulates the antiangiogenic effect of bone morphogenetic protein-4. Human umbilical vascular endothelial cells(HUVECs) and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates. Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. The assay was treated with VEGF, Suramin, recombinant human BMP-2, BMP-4, and CHL-1. Tubule formation was examined at day 11. Cells were fixed, quantitated, and visualized using a combined ELISA and histology kit. <bold>A</bold>: VEGF (2 ng/ml) and Suramin (20 mM) were used as positive and negative angiogenesis controls, respectively. B: Cells were treated with rhBMP-2 and rhBMP-4. BMP-4 significantly inhibited angiogenesis at 10 ng/ml. <bold>C</bold>: CHL-1 inhibited BMP-4; CHL-1 alone had no significant effect on angiogenesis, however it inhibited BMP-4s anti-angiogenic effects. Images <bold>A-C</bold> are shown at magnification 10X. Representative images are shown in <bold>A-C</bold>. <bold>D</bold>: Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, Ï-nitrophenol phosphate (Ï-NPP), which permits quantitation by an optical density measurement. The asterisk indicates a significance at p&lt;0.05 and the double asterisk indicates a significance at p&lt;0.001.</p>
          </caption>
          <graphic xlink:href="mv-v14-1138-f4"/>
        </fig>
        <fig id="f5" fig-type="figure" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Vascular endothelial growth factor and bone morphogenetic protein-4 co-regulate angiogenesis. Human umbilical vascular endothelial cells (HUVECs) and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates. Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. The assay was treated with vascular endothelial growth factor (VEGF), Suramin, and recombinant human BMP-4. Tubule formation was examined at day 11. Cells were fixed, quantitated, and visualized using a combined ELISA and histology kit. <bold>A</bold>: Angiogenesis assay demonstrating the combined effects of VEGF (pro-angiogenic) and BMP-4 (anti-angiogenic) on angiogenesis. Suramin was used as a negative control. (magnification 10X). Representative images are shown. <bold>B</bold>: Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, Ï-nitrophenol phosphate (Ï-NPP), which permits quantitation by an optical density measurement. Data are expressed as meanÂ±SEM values. The asterisk indicates a significance at p&lt;0.01 and the double asterisk indicates a significance at p&lt;0.001.</p>
          </caption>
          <graphic xlink:href="mv-v14-1138-f5"/>
        </fig>
      </sec>
      <sec>
        <title>Vascular endothelial growth factor and bone morphogenetic protein-4 co-regulate angiogenesis</title>
        <p>To examine whether the pro- and anti-angiogenic effects of VEGF and BMP-4 were mutually exclusive, we used these growth factors alone and in combination in an angiogenesis assay. We found 2 ng/ml VEGF stimulated angiogenesis and 10 ng/ml BMP-4 inhibited angiogenesis. In combination the two growth factors have no effect on angiogenesis (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The pathologic aberrations associated with diabetic retinopathy are localized primarily in the retinal capillaries. Pericyte loss and microaneurysm formation are hallmarks of early changes in the retinas of diabetic patients [<xref ref-type="bibr" rid="r23">23</xref>]. Retinal pericytes have been demonstrated to be involved in the regulation of endothelial cell number and morphology and microvessel architecture [<xref ref-type="bibr" rid="r8">8</xref>]. We have investigated the transcriptomic response of human retinal pericytes to hypoxic insult. Over three biologic replicate experiments, 35 genes (28 upregulated and seven downregulated) demonstrated differential expression after 48 h exposure to hypoxia. Among the upregulated genes were those whose expression has previously been associated with both hypoxia and diabetic retinopathy, such as <italic>VEGF</italic> [<xref ref-type="bibr" rid="r24">24</xref>â<xref ref-type="bibr" rid="r27">27</xref>] and <italic>Cox2</italic> [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. One gene, <italic>CHL-1</italic>/ventroptin has been described in the context of the developing retina [<xref ref-type="bibr" rid="r9">9</xref>]; however, its regulation or an association with a disease process is yet to be described.</p>
      <p>HIF-1Î± is a transcription factor implicated in hypoxia-elicited transcription. It binds HRE, a consensus element within promoters. We examined the promoters of the upregulated genes for the presence of the HIF-1Î± binding site (data not shown) and found 18 of the 27 upregulated genes contained HIF binding elements, including <italic>CHL-1</italic>. We also demonstrated increased nuclear presence of HIF-1Î± over a timecourse of exposure to hypoxia. Overexpression of HIF-1Î± drove the expression of many of the genes with HRE binding sites within their promoters, such as <italic>VEGF</italic>, <italic>Cox2</italic>, and <italic>CHL-1</italic>.</p>
      <p>Our data demonstrate that CHL-1 (Ventroptin, Neuralin-1), a BMP antagonist, is expressed by retinal pericytes in response to hypoxic insult. Its promoter contains binding sites for many transcription factors, including the known hypoxia responsive transcription factors HIF-1Î± and cyclic AMP response element-binding protein (CREB; data not shown). We have demonstrated that <italic>CHL-1</italic> mRNA expression and the <italic>CHL-1</italic> promoter is driven by hypoxia and by overexpressing HIF-1Î±. This suggests that HIF-1Î± contributes to the expression of CHL-1 in a hypoxic environment. Another possible regulator of CHL-1 expression may be VEGF, as <italic>VEGF</italic> mRNA is upregulated by hypoxia by 6h, it is possible it contributes to the upregulation of CHL-1 expression by 24h, as activation of the VEGF receptors activates multiple signaling pathways [<xref ref-type="bibr" rid="r29">29</xref>]and the precise regulation of the <italic>CHL-1</italic> promoter has yet to be defined.</p>
      <p>CHL-1 is a secreted protein expressed in the developing retina [<xref ref-type="bibr" rid="r9">9</xref>]. CHL-1 has three cysteine rich repeats (CRs). CRs are characteristic motifs that are conserved in some proteins including von Willebrand factor and chordin as well as other extracellular proteins, of which several are involved in regulation of BMP signaling regulation [<xref ref-type="bibr" rid="r30">30</xref>]. Because the three CRs of CHL-1 were significantly homologous to Chordin, Sakuta et al. [<xref ref-type="bibr" rid="r9">9</xref>] hypothesized and demonstrated that ventroptin (CHL-1) binds to and inhibits BMP-4. Another study demonstrated that ventroptin also inhibits BMP-2 [<xref ref-type="bibr" rid="r20">20</xref>]. This adds CHL-1 to a growing family of secretory proteins that antagonize BMPs, including chordin, Noggin, Cerberus, DAN, and Gremlin [<xref ref-type="bibr" rid="r31">31</xref>â<xref ref-type="bibr" rid="r34">34</xref>]. We have previously shown the BMP antagonist Gremlin to be upregulated in diabetic nephropathy [<xref ref-type="bibr" rid="r35">35</xref>,<xref ref-type="bibr" rid="r36">36</xref>] and localized to the outer retina of STZ diabetic mice [<xref ref-type="bibr" rid="r37">37</xref>]. Both BMP-2 and BMP-4 have been previously demonstrated to act as negative growth regulators in the retinal pigmented epithelium (RPE) [<xref ref-type="bibr" rid="r21">21</xref>]. We have found that human retinal pericytes express both BMP-2 and BMP-4. Other reports have shown decreases in BMP-4 in the retina in response to hypoxia [<xref ref-type="bibr" rid="r21">21</xref>]; however, in our study BMP-4 mRNA levels in retinal pericytes were unaffected by hypoxia. BMP-4 itself has been shown to promote apoptosis in the developing retina [<xref ref-type="bibr" rid="r38">38</xref>] and play a role in capillary apoptosis [<xref ref-type="bibr" rid="r22">22</xref>]. BMPs have also been demonstrated to stimulate angiogenesis through the production of VEGF [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r39">39</xref>]. We have shown that retinal pericytes not only express and secrete both BMP-2 and BMP-4, but they also secrete CHL-1 in response to hypoxic stimulus. Hypoxia is a well documented stimulus for angiogenesis and retinal neovascularization [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r41">41</xref>]. We have demonstrated here that hypoxia-induced HIF-1Î± drives CHL-1 expression in retinal pericytes, and that expressed recombinant V5-tagged CHL-1 binds BMP-4. Binding of CHL-1 to members of the BMP family has been previously demonstrated to modulate the function of the BMP [<xref ref-type="bibr" rid="r9">9</xref>]. Two studies showed regulation of angiogenesis by BMPs via <italic>VEGF</italic> [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r39">39</xref>]. More recently Vogt et al. [<xref ref-type="bibr" rid="r42">42</xref>] demonstrated that stimulation of ARPE-19 cells with BMP-4 results in increased VEGF expression. It has been documented that VEGFs secreted by epithelia, including the RPE, are likely to mediate paracrine vascular signals for adjacent endothelial (discussed in [<xref ref-type="bibr" rid="r43">43</xref>]). BMP-4 expression in the retina may have different effects on different cell types, such as increased VEGF expression from RPE cells and an anti-angiogenic effect on endothelial cells. In this study we demonstrated direct modulation of angiogenesis by BMP-4 in an in vitro angiogenesis assay and that this inhibition is modulated by the addition of CHL-1. We have also demonstrated that CHL-1 binds to BMP-4 and suggest that this binding prevents BMP-4 from acting at its receptor. Therefore, BMP-4 may play a role in the retina in maintaining capillary endothelial cell number, and the modulation of endogenous BMP levels in the retina may play a role in the plasticity of the retinal microvasculature in disease states. Induction of a BMP antagonist, namely CHL-1, by ischemic insult in a pathologic setting may function to neutralize BMP action on endothelial cells. Specifically, modulation of local BMP-4 activity in maintenance of capillary cell number by CHL-1, in response to a hypoxic environment, may contribute to retinal neovascularization, by allowing proliferation of endothelial cells. Gariano and Gardner [<xref ref-type="bibr" rid="r44">44</xref>] recently reviewed retinal angiogenesis and affirmed that pathological retinal neovascularization in the diabetic retina results from an imbalance of pro-angiogenic and anti-angiogenic factors. We have demonstrated in this study that angiogenic homeostasis may be maintained by such a combination, namely VEGF and BMP-4. We suggest that the balance between BMP-4 and VEGF is crucial in maintaining angiogenic homeostasis, and that the inhibition of the anti-angiogenic factor, BMP-4, by CHL-1, along with increases in VEGF tilt the balance in favor of a pro-angiogenic retinal environment.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>R.K. is the recipient of a Health Research Board, Ireland, Post-Doctoral Fellowship. Work in the authorâs laboratory is supported by Science Foundation Ireland, the Health Research Board, EU FP6 EICOSANOX consortium (LSHM-CT-2004-005033), and The Government of Irelandâs Programme for Research in Third Level Institutions (PRTLI) of the Higher Education Authority. We thank Dr. Cormac Taylor and Dr. Martin Leonard for helpful discussions and Catherine Moss for technical assistance.The accession numbers associated with the sequences in this study are <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=52078289">AY608913</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&amp;id=52078290">AY608914</ext-link>.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>The Eye Diseases Prevalence Research Group</collab>
          </person-group>
          <article-title>The Prevalence of Diabetic Retinopathy Among Adults in the United States.</article-title>
          <source>Arch Ophthalmol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>552</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">15078674</pub-id>
        </citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shweiki</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Itin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Soffer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Keshet</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>359</volume>
          <fpage>843</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">1279431</pub-id>
        </citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tolentino</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Gragoudas</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Jakobiec</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Flynn</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chatzistefanou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Adamis</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.</article-title>
          <source>Ophthalmology</source>
          <year>1996</year>
          <volume>103</volume>
          <fpage>1820</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">8942877</pub-id>
        </citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diaz-Flores</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gutierrez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Varela</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rancel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Valladares</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Microvascular pericytes: a review of their morphological and functional characteristics.</article-title>
          <source>Histol Histopathol</source>
          <year>1991</year>
          <volume>6</volume>
          <fpage>269</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">1802127</pub-id>
        </citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herman</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>D'Amore</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Microvascular pericytes contain muscle and nonmuscle actins.</article-title>
          <source>J Cell Biol</source>
          <year>1985</year>
          <volume>101</volume>
          <fpage>43</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">3891763</pub-id>
        </citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orlidge</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>D'Amore</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.</article-title>
          <source>J Cell Biol</source>
          <year>1987</year>
          <volume>105</volume>
          <fpage>1455</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">3654761</pub-id>
        </citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canfield</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Schor</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Schor</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Modulation of extracellular matrix biosynthesis by bovine retinal pericytes in vitro: effects of the substratum and cell density.</article-title>
          <source>J Cell Sci</source>
          <year>1990</year>
          <volume>96</volume>
          <fpage>159</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">2373739</pub-id>
        </citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>HellstrÃ¶m</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gerhardt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>KalÃ©n</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wolburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Betsholtz</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis.</article-title>
          <source>J Cell Biol</source>
          <year>2001</year>
          <volume>153</volume>
          <fpage>543</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">11331305</pub-id>
        </citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakuta</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shintani</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Iemura Si, Yamamoto TS, Ueno N, Noda M. Ventroptin: A BMP-4 Antagonist Expressed in a Double-Gradient Pattern in the Retina.</article-title>
          <source>Science</source>
          <year>2001</year>
          <volume>293</volume>
          <fpage>111</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">11441185</pub-id>
        </citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deckers</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>van Bezooijen</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>van der Horst</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hoogendam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van Der Bent</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Papapoulos</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>LÃ¶wik</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A.</article-title>
          <source>Endocrinology</source>
          <year>2002</year>
          <volume>143</volume>
          <fpage>1545</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">11897714</pub-id>
        </citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <citation citation-type="book">Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. Totowa, NJ: Humana Press; 2000.</citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Willam</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Pugh</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Ratcliffe</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Independent function of two destruction domains in hypoxia-inducible factor-{alpha} chains activated by prolyl hydroxylation.</article-title>
          <source>EMBO J</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>5197</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">11566883</pub-id>
        </citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Moncada</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1{alpha}.</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>302</volume>
          <fpage>1975</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">14671307</pub-id>
        </citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <citation citation-type="book">Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.</citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coffinier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Larrain</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>De Robertis</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Neuralin-1 is a novel Chordin-related molecule expressed in the mouse neural plate.</article-title>
          <source>Mech Dev</source>
          <year>2001</year>
          <volume>100</volume>
          <fpage>119</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">11118896</pub-id>
        </citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakayama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Scully</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishinakamura</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zeni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yamane</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yokota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A Novel Chordin-like Protein Inhibitor for Bone Morphogenetic Proteins Expressed Preferentially in Mesenchymal Cell Lineages.</article-title>
          <source>Dev Biol</source>
          <year>2001</year>
          <volume>232</volume>
          <fpage>372</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">11401399</pub-id>
        </citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aiello</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Northrup</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Keyt</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iwamoto</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Hypoxic regulation of vascular endothelial growth factor in retinal cells.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1995</year>
          <volume>113</volume>
          <fpage>1538</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">7487623</pub-id>
        </citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilkinson-Berka</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Alousis</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>974</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12601017</pub-id>
        </citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cryan</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Pidgeon</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Fitzgerald</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>COX-2 protects against thrombosis of the retinal vasculature in a mouse model of proliferative retinopathy.</article-title>
          <source>Mol Vis</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>405</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">16688111</pub-id>
        </citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shintani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakuta</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>CBF1 controls the retinotectal topographical map along the anteroposterior axis through multiple mechanisms.</article-title>
          <source>Development</source>
          <year>2003</year>
          <volume>130</volume>
          <fpage>5203</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">12954716</pub-id>
        </citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathura</surname>
              <given-names>JR</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Jafari</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Wahlin</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Della</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zack</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Campochiaro</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Bone Morphogenetic Proteins-2 and â4: Negative Growth Regulators in Adult Retinal Pigmented Epithelium.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>592</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">10670493</pub-id>
        </citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiyono</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shibuya</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression.</article-title>
          <source>Mol Cell Biol</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>4627</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">12808102</pub-id>
        </citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cogan</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Toussaint</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kuwabara</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Retinal vascular pattern. IV. Diabetic retinopathy.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1961</year>
          <volume>66</volume>
          <fpage>366</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">13694291</pub-id>
        </citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aiello</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Avery</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Arrigg</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Keyt</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Jampel</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Pasquale</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Thieme</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iwamoto</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Aiello</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders.</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>331</volume>
          <fpage>1480</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">7526212</pub-id>
        </citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forsythe</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Iyer</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Agani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Koos</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Semenza</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1.</article-title>
          <source>Mol Cell Biol</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>4604</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">8756616</pub-id>
        </citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Wegner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia.</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>13333</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">7768934</pub-id>
        </citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez-Elsner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Botella</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Velasco</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>CorbÃ½Â´</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Attisano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>BernabeÂ´</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Synergistic Cooperation between Hypoxia and Transforming Growth Factor-b Pathways on Human Vascular Endothelial Growth Factor Gene Expression.</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>38527</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">11486006</pub-id>
        </citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmedtje</surname>
              <given-names>JF</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Y-S</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W-L</given-names>
            </name>
            <name>
              <surname>DuBois</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Runge</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia Induces Cyclooxygenase-2 via the NF-kappa B p65 Transcription Factor in Human Vascular Endothelial Cells.</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>601</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">8995303</pub-id>
        </citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>CÃ©be-Suarez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zehnder-FjÃ¤llman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ballmer-Hofer</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The role of VEGF receptors in angiogenesis; complex partnerships</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>601</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">16465447</pub-id>
        </citation>
      </ref>
      <ref id="r30">
        <label>30</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia Abreu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coffinier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Larrain</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Oelgeschlager</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Robertis</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems.</article-title>
          <source>Gene</source>
          <year>2002</year>
          <volume>287</volume>
          <fpage>39</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">11992721</pub-id>
        </citation>
      </ref>
      <ref id="r31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biben</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stanley</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fabri</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kotecha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rhinn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Drinkwater</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hilton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ang</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Mohun</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Murine Cerberus Homologue mCer-1: A Candidate Anterior Patterning Molecule.</article-title>
          <source>Dev Biol</source>
          <year>1998</year>
          <volume>194</volume>
          <fpage>135</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">9501024</pub-id>
        </citation>
      </ref>
      <ref id="r32">
        <label>32</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Economides</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Eimon</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Harland</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>The Xenopus Dorsalizing Factor Gremlin Identifies a Novel Family of Secreted Proteins that Antagonize BMP Activities.</article-title>
          <source>Mol Cell</source>
          <year>1998</year>
          <volume>1</volume>
          <fpage>673</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">9660951</pub-id>
        </citation>
      </ref>
      <ref id="r33">
        <label>33</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearce</surname>
              <given-names>JJH</given-names>
            </name>
            <name>
              <surname>Penny</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rossant</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A Mouse Cerberus/Dan-Related Gene Family.</article-title>
          <source>Dev Biol</source>
          <year>1999</year>
          <volume>209</volume>
          <fpage>98</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">10208746</pub-id>
        </citation>
      </ref>
      <ref id="r34">
        <label>34</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Marvin</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Gardiner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lassar</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Mercola</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stern</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Levin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cerberus regulates left-right asymmetry of the embryonic head and heart.</article-title>
          <source>Curr Biol</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>931</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="pmid">10508582</pub-id>
        </citation>
      </ref>
      <ref id="r35">
        <label>35</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMahon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clarkson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mackenzie</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Godson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta 1.</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>9901</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">10744662</pub-id>
        </citation>
      </ref>
      <ref id="r36">
        <label>36</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dolan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sadlier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lappin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Doran</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Godson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>O'Meara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Henger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kretzler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Droguett</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mezzano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>of Gremlin, a Bone Morphogenetic Protein Antagonist, in Human Diabetic Nephropathy.</article-title>
          <source>Am J Kidney Dis</source>
          <year>2005</year>
          <volume>45</volume>
          <fpage>1034</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15957132</pub-id>
        </citation>
      </ref>
      <ref id="r37">
        <label>37</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kane</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Godson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stitt</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose.</article-title>
          <source>Br J Ophthalmol</source>
          <year>2005</year>
          <volume>89</volume>
          <fpage>1638</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">16299147</pub-id>
        </citation>
      </ref>
      <ref id="r38">
        <label>38</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trousse</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Esteve</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bovolenta</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>BMP4 Mediates Apoptotic Cell Death in the Developing Chick Eye.</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>1292</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="pmid">11160400</pub-id>
        </citation>
      </ref>
      <ref id="r39">
        <label>39</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos.</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2005</year>
          <volume>329</volume>
          <fpage>324</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">15721310</pub-id>
        </citation>
      </ref>
      <ref id="r40">
        <label>40</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maxwell</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Dachs</surname>
              <given-names>GU</given-names>
            </name>
            <name>
              <surname>Gleadle</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Nicholls</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Stratford</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Hankinson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pugh</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Ratcliffe</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumorÂ growth.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>8104</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">9223322</pub-id>
        </citation>
      </ref>
      <ref id="r41">
        <label>41</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Della</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Luna</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zack</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Semenza</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Campochiaro</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia inducible factor-1alpha is increased in </article-title>
          <source>Vis Sci</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>182</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">9888442</pub-id>
        </citation>
      </ref>
      <ref id="r42">
        <label>42</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogt</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Unda</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vidro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tsin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells.</article-title>
          <source>J Cell Biochem</source>
          <year>2006</year>
          <volume>98</volume>
          <fpage>1196</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">16514669</pub-id>
        </citation>
      </ref>
      <ref id="r43">
        <label>43</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witmer</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Vrensen</surname>
              <given-names>GFJM</given-names>
            </name>
            <name>
              <surname>Van Noorden</surname>
              <given-names>CJF</given-names>
            </name>
            <name>
              <surname>Schlingemann</surname>
              <given-names>RO</given-names>
            </name>
          </person-group>
          <article-title>Vascular endothelial growth factors and angiogenesis in eye disease.</article-title>
          <source>Prog Retin Eye Res</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>1</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">12597922</pub-id>
        </citation>
      </ref>
      <ref id="r44">
        <label>44</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gariano</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Retinal angiogenesis in development and disease.</article-title>
          <source>Nature</source>
          <year>2005</year>
          <volume>438</volume>
          <fpage>960</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">16355161</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>